1-(chlorodiphenylmethyl)naphthalene | 127787-73-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: 1-(chlorodiphenylmethyl)naphthalene
• 英文别名: 1-(α-chloro-benzhydryl)-naphthalene；1-(α-Chlor-benzhydryl)-naphthalin；Diphenyl-α-naphthyl-chlormethan；1-[Chloro(diphenyl)methyl]naphthalene
• CAS: 127787-73-9
• 化学式: C₂₃H₁₇Cl
• 分子量: 328.841
• InChiKey: SADZCJZAODOWTP-UHFFFAOYSA-N

物化性质

• 熔点：
  170-172 °C
• 沸点：
  473.4±14.0 °C(Predicted)
• 密度：
  1.181±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  6.7
• 重原子数：
  24
• 可旋转键数：
  3
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.04
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  0

反应信息

• 作为反应物：
  描述：

  1-(chlorodiphenylmethyl)naphthalene 在 氨 、 氯苯 作用下， 生成 (1-naphthyl)diphenylmethylamine
  参考文献：
  名称：

  Dilthey, Journal fur praktische Chemie (Leipzig 1954), 1925, vol. <2> 109, p. 316

  摘要：

  DOI：
• 作为产物：
  描述：

  phenylmagnesium bromide 在 盐酸 、 乙醚 作用下， 生成 1-(chlorodiphenylmethyl)naphthalene
  参考文献：
  名称：

  Dilthey, Journal fur praktische Chemie (Leipzig 1954), 1925, vol. <2> 109, p. 316

  摘要：

  DOI：

文献信息

• Photolysis of Triarylmethylphosphonic Acids and Their Esters
  作者：Min Shi、Yoshiki Okamoto、Setsuo Takamuku

  DOI：10.1246/bcsj.63.453

  日期：1990.2

  Upon UV-irradiation in an alkaline alcohol solution, some triarylmethylphosphonic acids underwent C–P bond cleavage to give triarylmethanes and alkyl dihydrogenphosphates, while, in an acidic or a neutral alcohol solution, they afforded biaryls. Their dimethyl esters gave also biaryls and dimethyl [alkoxy(aryl)methyl]phosphonates, which were derived from the insertion of (dialkoxyphosphinyl)arylcarbenes

  在碱性醇溶液中紫外线照射后，一些三芳基甲基膦酸发生 C-P 键断裂，得到三芳基甲烷和磷酸二氢烷基酯，而在酸性或中性醇溶液中，它们得到联芳基化合物。它们的二甲酯也产生联芳基和 [烷氧基（芳基）甲基]膦酸二甲酯，它们源自（二烷氧基膦基）芳基卡宾插入醇的 OH 键。卡宾是通过光-α,α-消除膦酸酯的两个芳基而产生的。
• Process for the preparation of substituted pyrrolidine neuraminidase inhibitors
  申请人：——

  公开号：US20030055297A1

  公开（公告）日：2003-03-20

  A process for the preparation of neuraminidase inhibitors having structural formula (28) 1 or therapeutically acceptable salts thereof, in which R 1 is alkyl, cycloalkyl, cycloalkylalkyl, or arylalkyl; R 2 is alkyl, cycloalkyl, cycloalkylalkyl, or arylalkyl; R 4 is alkyl, cycloalkyalkyl, or aryl-(C 2 -C 4 -alkyl); R 10 is methyl, ethyl, iso-propyl, or vinyl; and R 12 is hydrogen or alkyl and intermediates useful for the process are disclosed.

  一种用于制备具有结构式（28）1或其治疗上可接受的盐的神经氨酸酶抑制剂的方法，其中R1是烷基，环烷基，环烷基烷基或芳基烷基；R2是烷基，环烷基，环烷基烷基或芳基烷基；R4是烷基，环烷烷基或芳基（C2-C4-烷基）；R10是甲基，乙基，异丙基或乙烯基；和R12是氢或烷基，公开了用于该方法的中间体。
• Influence of Some Novel N-Substituted Azoles and Pyridines on Rat Hepatic CYP3A Activity
  作者：James T. Slama、Julie L. Hancock、Taikyun Rho、Lidia Sambucetti、Kenneth A. Bachmann

  DOI：10.1016/s0006-2952(98)00096-3

  日期：1998.6

  A series of N-substituted heteroaromatic compounds structurally related to clotrimazole was synthesized, and the effects of these compounds on ethosuximide clearance in rats were determined as a measure of their abilities to induce cytochrome P4503A (CYP3A) activity. Ethosuximide clearance and in vitro erythromycin N-demethylase activity were shown to correlate. In this series, imidazole or other related

  合成了一系列与克霉唑相关的N-取代杂芳族化合物，并确定了这些化合物对大鼠乙硫酰亚胺清除率的影响，以此来衡量它们诱导细胞色素P4503A（CYP3A）活性的能力。乙草胺清除率和体外红霉素N-脱甲基酶活性显示出相关性。在该系列中，咪唑或其他相关的杂芳族“头基”与三苯基甲烷或其他苯基甲烷衍生物连接。在该系列中，发现1-三苯基甲烷取代的咪唑引起CYP3A活性的最大增加，而在三苯基甲基取代的咪唑中，通过间位或Cl-中的F-或Cl-取代获得最高的活性。苯环之一的对位。二苯甲基取代的吡啶实际上没有活性。引起CYP3A活性最大增加的化合物（即1-[（（3-氟苯基）二苯基甲基]咪唑，1-[（（4-氟苯基）二苯基甲基]咪唑和1- [三-（4-氟苯基）甲基]咪唑）产生的乙氧基间苯二酚O-脱烷基酶（EROD）活性（即CYP1A）几乎没有增加，而苄基咪唑仅引起CYP3A活性少量增加，而CYP1A活性几乎增加了9倍。
• Process for production of vinyl chloride polymer
  申请人：Shin-Etsu Chemical Co., Ltd.

  公开号：EP0172427A2

  公开（公告）日：1986-02-26

  This process is a process for production of a vinyl chloride polymer by suspension polymerization or emulsion polymerization of vinyl chloride monomer or a mixture of vinyl chloride monomer with a vinyl monomer copolymerizable with said vinyl chloride monomer in an aqueous medium, characterized in that the polymerization is carried out in a polymerizer, the inner wall surface and portions of the auxiliary equipment thereof which may come into contact with the monomer during polymerization being previously coated with a scaling preventive comprising at least one selected from dyes, pigments and aromatic or heterocyclic compounds having at least 5 conjugated π bonds, while controlling the chloride ion concentration in the reaction mixture to not higher than 100 ppm. According to said process, scaling onto the inner wall surface of a polymerizer, etc. during polymerization can be prevented effectively and surely.

  该工艺是通过氯乙烯单体或氯乙烯单体与可与所述氯乙烯单体共聚的乙烯基单体混合物在水介质中进行悬浮聚合或乳液聚合来生产氯乙烯聚合物的工艺，其特征在于聚合是在聚合器中进行的、内壁表面及其辅助设备中可能在聚合过程中与单体接触的部分事先涂上一层防垢剂，该防垢剂至少包括一种选自染料、颜料和至少有 5 个共轭 π 键的芳香族或杂环化合物的防垢剂，同时控制反应混合物中的氯离子浓度不高于 100 ppm。根据上述工艺，可有效、可靠地防止聚合过程中聚合器等内壁表面结垢。
• ISOXAZOLE DERIVATIVES
  申请人：SANKYO COMPANY LIMITED

  公开号：EP0885891A1

  公开（公告）日：1998-12-23

  The isoxazole derivatives having the following general formula: [wherein R1 represents an optionally substituted aryl group or aromatic heterocyclic group; R2 represents a hydrogen atom, a halogen atom, an optionally substituted alkyl group, an alkenyl group, an alkynyl group, a cycloalkyl group, a cycloalkenyl group, an alkoxy group, a cyano group, a carboxyl group, an alkanoyl group, an alkoxycarbonyl group or an optionally substituted carbamoyl group; R3 represents an optionally substituted amino group or a saturated heterocyclic group; X represents an oxygen atom or a sulfur atom; n is an integer of from 2 to 6] has an excellent monoamine oxidase inhibitory activity, and is useful as a therapeutic agent or a preventive agent against nervous diseases such as depression.

  具有以下通式的异噁唑衍生物： [其中 R1 代表任选取代的芳基或芳香杂环基团；R2 代表氢原子、卤素原子、任选取代的烷基、烯基、炔基、环烷基、环烯基、烷氧基、氰基、羧基、烷酰基、烷氧羰基或任选取代的氨基甲酰基；R3 代表任选取代的氨基或饱和杂环基团；X 代表氧原子或硫原子；n 为 2 至 6 的整数]具有极佳的单胺氧化酶抑制活性，可用作治疗剂或预防剂，防治抑郁症等神经疾病。